DE602005004026T2 - Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen - Google Patents

Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen Download PDF

Info

Publication number
DE602005004026T2
DE602005004026T2 DE602005004026T DE602005004026T DE602005004026T2 DE 602005004026 T2 DE602005004026 T2 DE 602005004026T2 DE 602005004026 T DE602005004026 T DE 602005004026T DE 602005004026 T DE602005004026 T DE 602005004026T DE 602005004026 T2 DE602005004026 T2 DE 602005004026T2
Authority
DE
Germany
Prior art keywords
autism
pitx1
gene
disorder
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005004026T
Other languages
German (de)
English (en)
Other versions
DE602005004026D1 (de
Inventor
Anne Philippi
Francis Rousseau
Peter Brooks
Jörg Hager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntegraGen SA
Original Assignee
IntegraGen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntegraGen SA filed Critical IntegraGen SA
Publication of DE602005004026D1 publication Critical patent/DE602005004026D1/de
Application granted granted Critical
Publication of DE602005004026T2 publication Critical patent/DE602005004026T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE602005004026T 2004-07-01 2005-06-30 Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen Expired - Lifetime DE602005004026T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58413004P 2004-07-01 2004-07-01
US584130P 2004-07-01
PCT/IB2005/002319 WO2006003520A2 (en) 2004-07-01 2005-06-30 Human autism predisposition gene encoding a transcription factor and uses thereof

Publications (2)

Publication Number Publication Date
DE602005004026D1 DE602005004026D1 (de) 2008-02-07
DE602005004026T2 true DE602005004026T2 (de) 2008-12-24

Family

ID=35432082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005004026T Expired - Lifetime DE602005004026T2 (de) 2004-07-01 2005-06-30 Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen

Country Status (10)

Country Link
US (1) US20070218068A1 (https=)
EP (1) EP1761649B1 (https=)
JP (1) JP4949240B2 (https=)
AT (1) ATE382101T1 (https=)
AU (1) AU2005258838B2 (https=)
CA (1) CA2571365A1 (https=)
DE (1) DE602005004026T2 (https=)
ES (1) ES2299059T3 (https=)
IL (1) IL179751A (https=)
WO (1) WO2006003520A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110118135A1 (en) * 2008-01-09 2011-05-19 State Matthew W Mutations in Contaction Associated Protein 2 (CNTNAP2) are Associated with Increased Risk for Ideopathic Autism
WO2009150221A1 (en) * 2008-06-12 2009-12-17 Integragen A method for autism prediction
EP2963129A3 (en) * 2008-11-12 2016-05-11 University of Utah Research Foundation Autism associated genetic markers
WO2011067296A1 (en) 2009-12-01 2011-06-09 Integragen A combination of eight risk alleles associated with autism
KR101167942B1 (ko) 2010-02-12 2012-07-23 차의과학대학교 산학협력단 Ａｌｇ12 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 자폐 스펙트럼 장애 분석방법
CA2797319A1 (en) 2010-05-04 2011-11-10 Integragen A new combination of eight risk alleles associated with autism
EP2860265B1 (en) 2011-02-24 2016-10-26 The Chinese University of Hong Kong Determining fetal DNA percentage for twins
CN111808943B (zh) * 2020-06-18 2021-07-20 重庆浦洛通基因医学研究院有限公司 一种精神类个体化用药基因检测方法

Also Published As

Publication number Publication date
EP1761649A2 (en) 2007-03-14
ES2299059T3 (es) 2008-05-16
EP1761649B1 (en) 2007-12-26
WO2006003520A2 (en) 2006-01-12
CA2571365A1 (en) 2006-01-12
AU2005258838B2 (en) 2009-05-14
IL179751A0 (en) 2007-05-15
US20070218068A1 (en) 2007-09-20
JP4949240B2 (ja) 2012-06-06
WO2006003520A3 (en) 2006-03-02
JP2008504837A (ja) 2008-02-21
DE602005004026D1 (de) 2008-02-07
IL179751A (en) 2011-01-31
ATE382101T1 (de) 2008-01-15
AU2005258838A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
Sutherland et al. Genetics of migraine: insights into the molecular basis of migraine disorders
JP4048053B2 (ja) 特発性全身てんかんについてのローカス、当該ローカスのミューテーション、及びてんかんの評価、診断、予後、または治療のための当該ローカスの使用方法
DE69231734T2 (de) Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
Downs et al. Late‐onset progressive retinal atrophy in the G ordon and I rish S etter breeds is associated with a frameshift mutation in C2orf71
DE69734986T2 (de) Mutationen innerhalb der diabetes-suszeptibilitätsgene für die hepatozyten kernfaktoren (hnf) hnf-1alpha, hnf-1beta und hnf-4alpha
DE60026150T2 (de) Diagnostika und therapeutika für osteoporose
Li et al. Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families
DE602005004026T2 (de) Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen
EP1656458B1 (en) Human autism susceptibility gene and uses thereof
Shaikh et al. A new locus for nonsyndromic deafness DFNB51 maps to chromosome 11p13-p12
AU2006215385B2 (en) Uses of human autism susceptibility gene encoding a kinase
Lloyd et al. Haplotypes for type, degree, and rate of marbling in cattle are syntenic with human muscular dystrophy
US20080213765A1 (en) Human Autism Susceptibility Genes Encoding a Neurotransmitter Transporter and Uses Thereof
AU2006225995B2 (en) Human autism susceptibility gene encoding a transmembrane protein and uses thereof
US20060068387A1 (en) Genetic marker for endocrine disorders
DE60212861T2 (de) Verfahren zur Diagnose von Fettsucht
Knight Candidate gene studies in psychiatric illness
Verbeek The localization of and identification of novel SCA genes in the Dutch autosomal dominant cerebellar ataxia population
CH696239A5 (de) Alström-Syndrom, Genvarianten, codiertes Protein und Verfahren zur Diagnose des Alström-Syndroms.
WO2006003526A2 (en) Human autism susceptibility gene encoding otoa and uses thereof
Han Characterization of the Genes for Myoclonus-dystonia
GARAVITO © 2009 MARIA DEL PILAR GARAVITO
Hutcheson Examination of chromosome 7 in autism

Legal Events

Date Code Title Description
8364 No opposition during term of opposition